Skip to content

Therapeutic effects of steroid injection for benign vocal fold lesion

Therapeutic effects of steroid injection for benign vocal fold lesion - Steroid injection for benign vocal fold lesion

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047792
Enrollment
100
Registered
2022-06-01
Start date
2019-05-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign vocal fold lesion

Interventions

None listed

Sponsors

International University of Health and Welfare
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who have undergone intravocal steroid injection therapy since April 1, 2014

Exclusion criteria

Exclusion criteria: Patients with non-participation statement

Design outcomes

Primary

MeasureTime frame
Voice Handicap Index 3-4 months after injection

Secondary

MeasureTime frame
maximum phonation time, mean airflow rate, GRBAS scale

Countries

Japan

Contacts

Public ContactTakeharu Kanazawa

International University of Health and Welfare Tokyo Voice Center

kanatake@omiya.jichi.ac.jp03-3402-3151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026